文摘
An improved synthesis of the ketonucleoside 2'-Oxo-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-cytidine (6),an intermediate in the synthesis of the potent anti-tumor agent1 (MDL 101,731 or FMdC), is reported which incorporates atrifluoroacetic acid/dimethylsulfoxide oxidation process. Thisoxidation procedure eliminates the cryogenic reaction conditionsand the necessity of protection at the N-4 amine used in thepreviously published route. Simplified isolation procedures for3 and 4 eliminate two chromatographic purification steps.Overall yields are comparable to those reported previously.